Empery Asset Management, LP Unity Biotechnology, Inc. Transaction History

Empery Asset Management, LP

  • $16.8 Million
  • Q3 2022

A detailed history of Empery Asset Management, LP transactions in Unity Biotechnology, Inc. stock. As of the latest transaction made, Empery Asset Management, LP holds 4,411,645 shares of UBX stock, worth $5.69 Million. This represents 10.37% of its overall portfolio holdings.

Number of Shares
4,411,645
Holding current value
$5.69 Million
% of portfolio
10.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.4 - $4.27 $1.76 Million - $18.8 Million
4,411,645 New
4,411,645 $1.74 Million

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0
View Full List

About Unity Biotechnology, Inc.

UBX Quotes by TradingView
  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $18.1M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Empery Asset Management, LP Portfolio

Follow Empery Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empery Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Empery Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email